Bovine lactoferrin added to triple therapy increased Helicobacter pylori eradication rate
- Optimal Treatment of Helicobacter pylori With Ranitidine Bismuth Citrate (RBC): A Randomized Comparison Between Two 7--Day Triple Therapies and a 14--Day Dual Therapy. De Boer, Wink A.; Haeck, Peter W. E.; Often, Marten H.; Mulder, Chris J. J. // American Journal of Gastroenterology;Jul1998, Vol. 93 Issue 7, p1101
Objective: We investigated two promising 1-wk RBC-triple therapies in comparison to the already well investigated 2-wk RBC dual therapy. Methods: We conducted two randomized, open, parallel group studies in 13 hospitals in the Netherlands. H. pylori-positive patients without active ulceration...
- Continuing Medical Education Questions: December 2009. Scolapio, James S.; Kim, Karen C.; Ying Hong Wang; Atreja, Ashish; Dian Chiang // American Journal of Gastroenterology;Dec2009, Vol. 104 Issue 12, p3080
A quiz concerning the sequential therapy or triple therapy for helicobacter pylori infection is presented.
- Diagnosis of Helicobacter pylori Infection by Stool Antigen Determination: A Systematic Review. Gisbert, Javier P.; Pajares, José María // American Journal of Gastroenterology;Oct2001, Vol. 96 Issue 10, p2829
Recently a new, noninvasive diagnostic test based on the detection of Helicobacter pylori stool antigen (SA) has been developed. The aim of this study was to systematically review the experience on H. pylori SA test for the diagnosis of H. pylori infection....
- Eradication therapies for H. pylori. WALLING, ANNE D. // American Family Physician;1/15/1999, Vol. 59 Issue 2, p470
Presents information on eradication therapies for Helicobacter pylori infections. Recommended regimens; Efficacy rates; Alternative therapies.
- Helicobacter pylori Infection in Skin Diseases. Bamford, J.T.M. // American Journal of Clinical Dermatology;2002, Vol. 3 Issue 8, p579
Comments on a study about the eradication of Helicobacter pylori in patients with chronic urticaria with Helicobacter pylori infection. Assertion of the study that contradict the eradication of Helicobacter pylori; Factors that should be considered in removing Helicobacter pylori.
- CLOSTRIDIUM DIFFICILE COLITIS ASSOCIATED WITH TREATMENT OF HELICOBACTER PYLORI INFECTION. Nawaz, A.; Mohammed, I.; Ahsan, K.; Karakurum, A.; Hadjiyane, C.; Pellecchia, C. // American Journal of Gastroenterology;Jul1998, Vol. 93 Issue 7, p1175
Helicobacter pylori infection of the stomach is being detected and treated more often now than ever before. This is likely to result in an increase in complications such as antibiotic-associated diarrhea. However, there is no literature on the incidence of such diarrhea, particularly Clostridium...
- ONE-WEEK TRIPLE THERAPY HEALS PEPTIC ULCERS. // Cortlandt Forum;12/20/2005, Vol. 18 Issue 12, p64
The article presents a question answer advisory wherein a reader asks about new developments in the field of ulcer therapy. Proton pump inhibitor-based triple therapy for about one week is reported to be as effective as similar therapy for peptic ulcer patients with Helicobacter pylori...
- Two-Day Quadruple Therapy for Cure of Helicobacter pylori Infection: A Comparative, Randomized Trial. Calvet, X.; García, N.; Campo, R.; Brullet, E.; Comet, R.; Navarro, M. // American Journal of Gastroenterology;Jun1998, Vol. 93 Issue 6, p932
Objective: We sought to compare a 2-day quadruple therapy with a 14-day triple therapy in the treatment of Helicobacter pylori infection. Methods: Eighty-one consecutive patients with an endoscopically diagnosed peptic ulcer and demonstrated infection by H. pylori were included...
- The Prevalence of Helicobacter Pylori Infection in Obese and Non-Obese Subjects Attending the Endoscopy Unit. Hashim, Ahmed Morad; Abualsel, Abdulmenem; Mostafa, Neveen Rashad; Obaid, Jenan // Bahrain Medical Bulletin;Dec2015, Vol. 37 Issue 4, p234
Background: Obesity is a rising public health problem and has steadily become a worldwide epidemic. The prevalence of H. pylori infection in obese patients is still controversial. Many studies reported a lower prevalence of H. pylori in obese patients compared to non-obese patients, others...